Caution Urged for Obesity Drugs and Birth Control Pills Caution Urged for Obesity Drugs and Birth Control Pills
GLP-1 agonists can interfere with oral contraceptives, making an unintended pregnancy more likely.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 18, 2023 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news
Navigating Key Endpoints in Oncology Clinical Trials Navigating Key Endpoints in Oncology Clinical Trials
Here ' s a guide to understanding endpoints you will likely encounter in cancer clinical trials.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 18, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news
Metabolic Effects of Estetrol for Postmenopausal Women Metabolic Effects of Estetrol for Postmenopausal Women
Participants taking estetrol experienced beneficial changes across a variety of metabolic measures, according to a new study presented at the Menopause Society.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 17, 2023 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news
Don ’t Stop OUD Drugs Before Surgery: Study Don ’t Stop OUD Drugs Before Surgery: Study
Medications for opioid use disorder protect against overdoses and postsurgical complications, researchers found.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 16, 2023 Category: Drugs & Pharmacology Tags: Anesthesiology News Source Type: news
Docs Weigh In on Insurance Coverage for Obesity Medications Docs Weigh In on Insurance Coverage for Obesity Medications
Supply and demand issues and rising costs drove some insurers to cut coverage.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 13, 2023 Category: Drugs & Pharmacology Tags: Internal Medicine News Source Type: news
FDA Approves New Drug for Ulcerative Colitis FDA Approves New Drug for Ulcerative Colitis
Etrasimod is the second oral sphingosine-1-phosphate (S1P) receptor approved in the US for treating moderate to severe active ulcerative colitis in adults.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 13, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news
Proton Pump Inhibitors Linked to Increased Dementia Risk Proton Pump Inhibitors Linked to Increased Dementia Risk
The risk for a dementia diagnosis before age 90 years was significantly higher among people with a history of PPI use, especially those who were diagnosed at a younger age.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 11, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news
Adverse Events Compared for Gout Flare Prophylactic Drugs Adverse Events Compared for Gout Flare Prophylactic Drugs
Patients receiving prophylactic colchicine or NSAIDs with initiation of allopurinol for gout have more adverse events than those who receive no prophylaxis, but these events are rare overall.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 6, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
GLP-1 Agonists Linked to Higher Risk for GI Complications GLP-1 Agonists Linked to Higher Risk for GI Complications
Compared with naltrexone/bupropion for weight loss, semaglutide and liraglutide were associated with a higher risk for three adverse gastrointestinal outcomes.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 5, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
NCCN Survey Shows Ongoing Chemo Drug Shortages NCCN Survey Shows Ongoing Chemo Drug Shortages
Nearly 90% of NCCN member institutions that responded to a September survey reported a shortage of at least one anticancer agent.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 5, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news
QA Measures for Bone Care Falling Short, Group Says QA Measures for Bone Care Falling Short, Group Says
Clinicians described several strategies for treating osteoporosis while acknowledging that commonly used quality assessments need work.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 3, 2023 Category: Drugs & Pharmacology Tags: Internal Medicine News Source Type: news
Hyaluronic Acid Suppository Improves Menopause Symptoms Hyaluronic Acid Suppository Improves Menopause Symptoms
In a randomized trial, treatment with vaginal hyaluronic acid or vaginal estrogen benefitted patients with genitourinary syndrome of menopause.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 29, 2023 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news
ADC Toxicities: The Price You Pay for Efficacy ADC Toxicities: The Price You Pay for Efficacy
Understanding the toxicities associated with antibody-drug conjugates could help oncologists develop strategies to diminish adverse events that arise during treatment with these powerful agentsMedscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 29, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news
FDA Panel Rejects Experimental Stem Cell Therapy for ALS FDA Panel Rejects Experimental Stem Cell Therapy for ALS
An FDA advisory panel resoundingly rejected NurOwn, an experimental stem cell therapy for mild to moderate ALS.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 28, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news
FDA Review Skeptical of ALS Stem Cell Therapy FDA Review Skeptical of ALS Stem Cell Therapy
The FDA has raised concerns about the safety and efficacy of an experimental stem cell therapy for ALS scheduled for a public hearing by a federal advisory panel on Wednesday.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 27, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news
